封面
市場調查報告書
商品編碼
1922541

日本家庭輸液治療市場報告:按產品、應用和地區分類(2026-2034年)

Japan Home Infusion Therapy Market Report by Product, Application, and Region 2026-2034

出版日期: | 出版商: IMARC | 英文 119 Pages | 商品交期: 5-7個工作天內

價格
簡介目錄

2025年,日本家庭輸液治療市場規模為28.622億美元。展望未來,IMARC Group預測,到2034年,該市場規模將達到49.476億美元,2026年至2034年的複合年成長率(CAGR)為6.27%。慢性病盛行率的上升、居家醫療需求的成長以及產品供應的不斷進步是推動市場成長的主要因素。

居家輸液治療(HOMET)是一種特殊的醫療程序,它利用包括輸液幫浦、導管和管瓶的各種設備,在患者舒適的家中透過靜脈注射輸注藥物、液體和營養物質,例如抗病毒藥物和免疫球蛋白。對於需要長期或頻繁靜脈輸液治療的感染疾病、癌症或慢性疾病(例如多發性硬化症 (MS) 和類風濕性關節炎)患者,建議採用此療法。居家輸液治療為患者帶來舒適和便利,提高他們的生活品質,並降低醫院感染的風險。它也能讓病人在接受所需照護的同時,保持治療的獨立性和自主性,從而增強他們的自主權。居家輸液治療對多種治療尤其有效,包括化療、補液、經腸營養正性肌力藥物、抗感染劑、營養支持和疼痛管理。它被廣泛用於治療糖尿病、各種胃腸道疾病和腫瘤。

日本家庭輸液治療市場的發展趨勢:

由於癌症、骨關節炎、人類免疫力缺乏病毒(HIV)和糖尿病等慢性疾病的日益普遍,日本的家庭輸液治療市場正經歷顯著成長。老年人口的成長,尤其是那些容易罹患危及生命的疾病、需要定期醫療照護(特別是輸液治療)的老年人,也大大促進了市場成長。此外,政府的各項措施、優惠的報銷政策以及長期住院費用的不斷上漲,都促使患者選擇家庭輸液治療,進一步推動了市場擴張。居家醫療服務的便利性和成本效益日益受到青睞,加之醫院資源日益緊張,這些因素也進一步促進了成長要素。由於長期接觸受污染的醫療設備、床單和飛沫,醫院感染(HAI)的增加也推動了市場擴張。對需要特殊給藥方式的特殊藥物的廣泛需求,也是推動市場成長的重要因素。此外,輕巧、攜帶式、易於使用的輸液泵的開發,以及先進的滴注系統,能夠對輸液治療進行精確和即時的監測,這些創新技術進步預計將在預測期內推動市場成長。

本報告解答的關鍵問題

  • 日本家庭輸液治療市場目前發展狀況如何?未來幾年又將如何發展?
  • 新冠疫情對日本家庭輸液治療市場產生了哪些影響?
  • 日本家庭輸液治療市場的產品組成是什麼?
  • 日本家庭輸液治療市場按應用領域分類的市場區隔如何?
  • 日本家庭輸液治療市場價值鏈的不同階段有哪些?
  • 日本家庭輸液治療的主要促進因素和挑戰是什麼?
  • 日本家庭輸液治療市場的結構是怎麼樣的?主要參與者有哪些?
  • 日本家庭輸液治療市場競爭有多激烈?

目錄

第1章:序言

第2章:調查範圍與調查方法

  • 調查目標
  • 相關利益者
  • 數據來源
  • 市場估值
  • 調查方法

第3章執行摘要

第4章:日本家庭輸液治療市場-引言

  • 概述
  • 市場動態
  • 產業趨勢
  • 競爭資訊

第5章 日本家庭輸液治療市場概覽

  • 過去和當前的市場趨勢(2020-2025)
  • 市場預測(2026-2034)

第6章 日本家庭輸液治療市場-依產品細分

  • 點滴幫浦
  • 靜脈輸液裝置
  • 靜脈插管
  • 無針頭連接器

第7章 日本家庭輸液治療市場-依應用領域細分

  • 抗感染劑
  • 內分泌學
  • 水療法
  • 化療
  • 經腸營養
  • 腸外營養
  • 特種藥品
  • 其他

第8章:日本家庭輸液治療市場:依地區分類

  • 關東地區
  • 關西、近畿地區
  • 中部地區
  • 九州和沖繩地區
  • 東北部地區
  • 中國地區
  • 北海道地區
  • 四國地區

第9章:日本家庭輸液治療市場:競爭格局

  • 概述
  • 市場結構
  • 市場公司定位
  • 關鍵成功策略
  • 競爭對手儀錶板
  • 企業估值象限

第10章主要企業概況

第11章:日本家庭輸液治療市場:產業分析

  • 促進因素、限制因素和機遇
  • 波特五力分析
  • 價值鏈分析

第12章附錄

簡介目錄
Product Code: SR112026A19967

Japan home infusion therapy market size reached USD 2,862.2 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 4,947.6 Million by 2034, exhibiting a growth rate (CAGR) of 6.27% during 2026-2034 . The growing incidence of chronic illnesses, the rising inclination towards home healthcare, and continuous advancements in product offerings are among the primary factors propelling the market growth.

Access the full market insights report Request Sample

Home infusion therapy is a specialized medical treatment that involves delivering medications, such as antivirals or immune globulin, fluids, or nutrition intravenously to patients in the comfort of their homes, utilizing various equipment like pumps, catheters, and vials. This form of therapy is recommended for individuals dealing with infections, cancer, or chronic conditions like multiple sclerosis (MS) or rheumatoid arthritis that necessitate long-term or frequent infusion treatment. Home infusion therapy provides a sense of comfort and convenience, enhances the overall quality of life, and diminishes the risk of hospital-acquired infections. Moreover, it empowers patients by allowing them to maintain a sense of independence and control over their treatment while still receiving essential medical care. Home infusion therapy is particularly effective in diverse treatments, including chemotherapy, hydration, enteral, inotropic, anti-infective, nutritional, and pain management therapies, commonly employed for conditions such as diabetes and various gastrointestinal and oncological disorders.

JAPAN HOME INFUSION THERAPY MARKET TRENDS:

The Japan home infusion therapy market is witnessing substantial growth, driven by an increase in the prevalence of chronic diseases like cancer, osteoarthritis, human immunodeficiency viruses (HIV), and diabetes. The expanding geriatric population, more susceptible to life-threatening illnesses requiring regular medical attention, particularly infusion therapy, is also contributing significantly to market growth. Besides this, government initiatives, favorable reimbursement policies, and the rising costs associated with prolonged hospital stays are motivating patients to opt for home infusion therapy, further fueling market expansion. Additionally, the growing preference for home healthcare services due to their convenience and cost-effectiveness, coupled with the increasing strain on hospital resources, is acting as another significant growth-inducing factor. Apart from this, the rise in hospital-acquired infections (HAIs) due to prolonged exposure to contaminated equipment, bed linens, and air droplets is amplifying the market's expansion. The widespread demand for specialty drugs, necessitating specialized administration, adds another layer of growth to the market. Furthermore, innovative technological advancements, such as the development of lightweight, portable, and user-friendly infusion pumps equipped with advanced drip systems for precise and real-time monitoring of IV treatments, are anticipated to fuel the market growth over the forecasted period.

JAPAN HOME INFUSION THERAPY MARKET SEGMENTATION:

Product Insights:

  • To get detailed segment analysis of this market Request Sample
  • Infusion Pumps Elastomeric Electromechanical Gravity Others
  • Elastomeric
  • Electromechanical
  • Gravity
  • Others
  • Intravenous Sets
  • IV Cannulas
  • Needleless Connectors
  • Infusion Pumps Elastomeric Electromechanical Gravity Others
  • Elastomeric
  • Electromechanical
  • Gravity
  • Others
  • Elastomeric
  • Electromechanical
  • Gravity
  • Others
  • Elastomeric
  • Electromechanical
  • Gravity
  • Others
  • Intravenous Sets
  • IV Cannulas
  • Needleless Connectors

Application Insights:

  • Anti-Infective
  • Endocrinology Diabetes Others
  • Diabetes
  • Others
  • Hydration Therapy Athletes Others
  • Athletes
  • Others
  • Chemotherapy
  • Enteral Nutrition
  • Parenteral Nutrition
  • Specialty Pharmaceuticals
  • Others
  • Anti-Infective
  • Endocrinology Diabetes Others
  • Diabetes
  • Others
  • Diabetes
  • Others
  • Diabetes
  • Others
  • Hydration Therapy Athletes Others
  • Athletes
  • Others
  • Athletes
  • Others
  • Athletes
  • Others
  • Chemotherapy
  • Enteral Nutrition
  • Parenteral Nutrition
  • Specialty Pharmaceuticals
  • Others

Regional Insights:

  • To get detailed regional analysis of this market Request Sample
  • Kanto Region
  • Kansai/Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • Kanto Region
  • Kansai/Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

COMPETITIVE LANDSCAPE:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

  • KEY QUESTIONS ANSWERED IN THIS REPORT
  • How has the Japan home infusion therapy market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan home infusion therapy market?
  • What is the breakup of the Japan home infusion therapy market on the basis of product?
  • What is the breakup of the Japan home infusion therapy market on the basis of application?
  • What are the various stages in the value chain of the Japan home infusion therapy market?
  • What are the key driving factors and challenges in the Japan home infusion therapy?
  • What is the structure of the Japan home infusion therapy market and who are the key players?
  • What is the degree of competition in the Japan home infusion therapy market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Home Infusion Therapy Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Home Infusion Therapy Market Landscape

  • 5.1 Historical and Current Market Trends (2020-2025)
  • 5.2 Market Forecast (2026-2034)

6 Japan Home Infusion Therapy Market - Breakup by Product

  • 6.1 Infusion Pumps
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2020-2025)
    • 6.1.3 Market Segmentation
      • 6.1.3.1 Elastomeric
      • 6.1.3.2 Electromechanical
      • 6.1.3.3 Gravity
      • 6.1.3.4 Others
    • 6.1.4 Market Forecast (2026-2034)
  • 6.2 Intravenous Sets
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2020-2025)
    • 6.2.3 Market Forecast (2026-2034)
  • 6.3 IV Cannulas
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2020-2025)
    • 6.3.3 Market Forecast (2026-2034)
  • 6.4 Needleless Connectors
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2020-2025)
    • 6.4.3 Market Forecast (2026-2034)

7 Japan Home Infusion Therapy Market - Breakup by Application

  • 7.1 Anti-Infective
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2020-2025)
    • 7.1.3 Market Forecast (2026-2034)
  • 7.2 Endocrinology
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2020-2025)
    • 7.2.3 Market Segmentation
      • 7.2.3.1 Diabetes
      • 7.2.3.2 Others
    • 7.2.4 Market Forecast (2026-2034)
  • 7.3 Hydration Therapy
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2020-2025)
    • 7.3.3 Market Segmentation
      • 7.3.3.1 Athletes
      • 7.3.3.2 Others
    • 7.3.4 Market Forecast (2026-2034)
  • 7.4 Chemotherapy
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2020-2025)
    • 7.4.3 Market Forecast (2026-2034)
  • 7.5 Enteral Nutrition
    • 7.5.1 Overview
    • 7.5.2 Historical and Current Market Trends (2020-2025)
    • 7.5.3 Market Forecast (2026-2034)
  • 7.6 Parenteral Nutrition
    • 7.6.1 Overview
    • 7.6.2 Historical and Current Market Trends (2020-2025)
    • 7.6.3 Market Forecast (2026-2034)
  • 7.7 Specialty Pharmaceuticals
    • 7.7.1 Overview
    • 7.7.2 Historical and Current Market Trends (2020-2025)
    • 7.7.3 Market Forecast (2026-2034)
  • 7.8 Others
    • 7.8.1 Historical and Current Market Trends (2020-2025)
    • 7.8.2 Market Forecast (2026-2034)

8 Japan Home Infusion Therapy Market - Breakup by Region

  • 8.1 Kanto Region
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2020-2025)
    • 8.1.3 Market Breakup by Product
    • 8.1.4 Market Breakup by Application
    • 8.1.5 Key Players
    • 8.1.6 Market Forecast (2026-2034)
  • 8.2 Kansai/Kinki Region
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2020-2025)
    • 8.2.3 Market Breakup by Product
    • 8.2.4 Market Breakup by Application
    • 8.2.5 Key Players
    • 8.2.6 Market Forecast (2026-2034)
  • 8.3 Central/ Chubu Region
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2020-2025)
    • 8.3.3 Market Breakup by Product
    • 8.3.4 Market Breakup by Application
    • 8.3.5 Key Players
    • 8.3.6 Market Forecast (2026-2034)
  • 8.4 Kyushu-Okinawa Region
    • 8.4.1 Overview
    • 8.4.2 Historical and Current Market Trends (2020-2025)
    • 8.4.3 Market Breakup by Product
    • 8.4.4 Market Breakup by Application
    • 8.4.5 Key Players
    • 8.4.6 Market Forecast (2026-2034)
  • 8.5 Tohoku Region
    • 8.5.1 Overview
    • 8.5.2 Historical and Current Market Trends (2020-2025)
    • 8.5.3 Market Breakup by Product
    • 8.5.4 Market Breakup by Application
    • 8.5.5 Key Players
    • 8.5.6 Market Forecast (2026-2034)
  • 8.6 Chugoku Region
    • 8.6.1 Overview
    • 8.6.2 Historical and Current Market Trends (2020-2025)
    • 8.6.3 Market Breakup by Product
    • 8.6.4 Market Breakup by Application
    • 8.6.5 Key Players
    • 8.6.6 Market Forecast (2026-2034)
  • 8.7 Hokkaido Region
    • 8.7.1 Overview
    • 8.7.2 Historical and Current Market Trends (2020-2025)
    • 8.7.3 Market Breakup by Product
    • 8.7.4 Market Breakup by Application
    • 8.7.5 Key Players
    • 8.7.6 Market Forecast (2026-2034)
  • 8.8 Shikoku Region
    • 8.8.1 Overview
    • 8.8.2 Historical and Current Market Trends (2020-2025)
    • 8.8.3 Market Breakup by Product
    • 8.8.4 Market Breakup by Application
    • 8.8.5 Key Players
    • 8.8.6 Market Forecast (2026-2034)

9 Japan Home Infusion Therapy Market - Competitive Landscape

  • 9.1 Overview
  • 9.2 Market Structure
  • 9.3 Market Player Positioning
  • 9.4 Top Winning Strategies
  • 9.5 Competitive Dashboard
  • 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

  • 10.1 Company A
    • 10.1.1 Business Overview
    • 10.1.2 Product Portfolio
    • 10.1.3 Business Strategies
    • 10.1.4 SWOT Analysis
    • 10.1.5 Major News and Events
  • 10.2 Company B
    • 10.2.1 Business Overview
    • 10.2.2 Product Portfolio
    • 10.2.3 Business Strategies
    • 10.2.4 SWOT Analysis
    • 10.2.5 Major News and Events
  • 10.3 Company C
    • 10.3.1 Business Overview
    • 10.3.2 Product Portfolio
    • 10.3.3 Business Strategies
    • 10.3.4 SWOT Analysis
    • 10.3.5 Major News and Events
  • 10.4 Company D
    • 10.4.1 Business Overview
    • 10.4.2 Product Portfolio
    • 10.4.3 Business Strategies
    • 10.4.4 SWOT Analysis
    • 10.4.5 Major News and Events
  • 10.5 Company E
    • 10.5.1 Business Overview
    • 10.5.2 Product Portfolio
    • 10.5.3 Business Strategies
    • 10.5.4 SWOT Analysis
    • 10.5.5 Major News and Events

11 Japan Home Infusion Therapy Market - Industry Analysis

  • 11.1 Drivers, Restraints, and Opportunities
    • 11.1.1 Overview
    • 11.1.2 Drivers
    • 11.1.3 Restraints
    • 11.1.4 Opportunities
  • 11.2 Porters Five Forces Analysis
    • 11.2.1 Overview
    • 11.2.2 Bargaining Power of Buyers
    • 11.2.3 Bargaining Power of Suppliers
    • 11.2.4 Degree of Competition
    • 11.2.5 Threat of New Entrants
    • 11.2.6 Threat of Substitutes
  • 11.3 Value Chain Analysis

12 Appendix